DNA methylation of microRNA‐coding genes in non‐small‐cell lung cancer patients
Open Access
- 20 June 2018
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 245 (4) , 387-398
Abstract
Deregulated DNA methylation leading to transcriptional inactivation of certain genes occurs frequently in non‐small‐cell lung cancers (NSCLCs). As well as protein‐coding genes, microRNA (miRNA)‐coding genes may be targets for methylation in NSCLCs; however, the number of known methylated miRNA genes is still small. Thus, we investigated methylation of miRNA genes in primary tumour (TU) samples and corresponding non‐malignant lung tissue (NL) samples of 50 NSCLC patients by using methylated DNA immunoprecipitation followed by custom‐designed tiling microarray analyses (MeDIP‐chip), and 252 differentially methylated probes between TU samples and NL samples were identified. These probes were annotated, which resulted in the identification of 34 miRNA genes with increased methylation in TU samples. Some of these miRNA genes were already known to be methylated in NSCLCs (e.g. those encoding miR‐9‐3 and miR‐124), but methylation of the vast majority of them was previously unknown. We selected six miRNA genes (those encoding miR‐10b, miR‐1179, miR‐137, miR‐572, miR‐3150b, and miR‐129‐2) for gene‐specific methylation analyses in TU samples and corresponding NL samples of 104 NSCLC patients, and observed a statistically significant increase in methylation of these genes in TU samples (p < 0.0001). In silico target prediction of the six miRNAs identified several oncogenic/cell proliferation‐promoting factors (e.g. CCNE1 as an miR‐1179 target). To investigate whether miR‐1179 indeed targets CCNE1, we transfected miR‐1179 gene mimics into CCNE1‐expressing NSCLC cells, and observed downregulated CCNE1 mRNA expression in these cells as compared with control cells. Similar effects on cyclin E1 expression were seen in western blot analyses. In addition, we found a statistically significant reduction in the growth of NSCLC cells transfected with miR‐1179 mimics as compared with control cells. In conclusion, we identified many methylated miRNA genes in NSCLC patients, and found that the miR‐1179 gene is a potential tumour cell growth suppressor in NSCLCs. Overall, our findings emphasize the impact of miRNA gene methylation on the pathogenesis of NSCLCs. © 2018 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Austrian Science Fund (P24130, SFB F4709‐B20)
- Medizinische Universität Wien
This publication has 60 references indexed in Scilit:
- The UCSC Cancer Genomics Browser: update 2013Nucleic Acids Research, 2012
- Functions of DNA methylation: islands, start sites, gene bodies and beyondNature Reviews Genetics, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- miRNAs in human cancerThe Journal of Pathology, 2010
- microRNAs and lung cancer: tumors and 22-mersCancer and Metastasis Reviews, 2010
- MiRNAs and CancerThe American Journal of Pathology, 2009
- A microRNA DNA methylation signature for human cancer metastasisProceedings of the National Academy of Sciences, 2008
- MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3BProceedings of the National Academy of Sciences, 2007
- The Human let-7a-3 Locus Contains an Epigenetically Regulated MicroRNA Gene with Oncogenic FunctionCancer Research, 2007
- MicroRNAs: small RNAs with a big role in gene regulationNature Reviews Genetics, 2004